Company Filing History:
Years Active: 2017-2024
Title: Innovations by Franz Kappel in Virtual Clinical Trials and Hemodialysis
Introduction
Franz Kappel is a notable inventor based in Graz, Austria, recognized for his contributions to medical technology. He holds a total of seven patents, showcasing his innovative approach to improving healthcare practices. His work primarily focuses on virtual clinical trials and hemodialysis, addressing critical challenges in these fields.
Latest Patents
Kappel's latest patents include groundbreaking techniques for conducting virtual clinical trials. These techniques and apparatus are designed to generate, perform, and evaluate virtual clinical trials that incorporate clinic modules to represent real-world operational aspects of trial entities. One embodiment of his invention features an apparatus that includes at least one memory and logic configured to generate a plurality of avatars. These avatars model health conditions associated with a population of patients and simulate treatment courses in a virtual clinical trial. The trials include clinic modules associated with events that model operational aspects of the trial entities.
Another significant patent focuses on a system for analyzing vascular refill during short-pulse ultrafiltration in hemodialysis. This method involves receiving measurements of a blood-related parameter from a patient undergoing hemodialysis. It estimates treatment-related parameters by applying a vascular refill model based on these measurements. The model is a two-compartment system that separates blood plasma and interstitial fluid, providing insights into the effects of vascular refill on patients during treatment.
Career Highlights
Franz Kappel is currently employed at Fresenius Medical Care Holdings, Inc., a leading company in the healthcare sector. His work at this organization allows him to apply his innovative ideas to real-world medical challenges, enhancing patient care and treatment outcomes.
Collaborations
Kappel collaborates with esteemed colleagues such as Peter Kotanko and Stephan Thijssen. Their combined expertise contributes to the advancement of medical technologies and the development of effective treatment methodologies.
Conclusion
Franz Kappel's innovative patents and contributions to virtual clinical trials and hemodialysis exemplify his commitment to improving healthcare. His work continues to influence the medical field, paving the way for future advancements in patient treatment and care.